Rafael Amado

Insider Reports History

Entity
Individual
Location
210 East Grand Ave, South San Francisco, CA
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rafael Amado:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. EVP of R&D Common Stock 542K $1.72M $3.17 Oct 7, 2022 Direct
Zai Lab Ltd President, Head of Global Oncology Research and Development American Depositary Shares 20.4K $331K $16.20 Aug 12, 2024 Direct
Zai Lab Ltd President, Head of Global Oncology Research and Development Restricted Share Units 16.2K $261K $16.15 Apr 3, 2024 Direct
Poseida Therapeutics, Inc. Director Common Stock 59K $243K $4.13 Jun 17, 2024 Direct
Zai Lab Ltd President, Head of Global Oncology Research and Development Stock Options (Right to Buy) 120K Apr 1, 2024 Direct
Poseida Therapeutics, Inc. Director Stock Option (Right to buy) 27.4K Jun 17, 2024 Direct

Insider Reports Filed by Rafael Amado

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZLAB Zai Lab Ltd Aug 12, 2024 1 -$50.5K 4 Aug 14, 2024 President, Head of Global Oncology Research and Development
PSTX Poseida Therapeutics, Inc. Jun 17, 2024 2 $0 4 Jun 18, 2024 Director
ZLAB Zai Lab Ltd Apr 3, 2024 3 $55.1K 4 Apr 5, 2024 President, Head of Global Oncology Research and Development
ZLAB Zai Lab Ltd Apr 1, 2024 2 $0 4 Apr 3, 2024 President, Head of Global Oncology Research and Development
ZLAB Zai Lab Ltd Mar 15, 2024 1 -$48K 4 Mar 19, 2024 President, Head of Global Oncology Research and Development
ZLAB Zai Lab Ltd Dec 29, 2023 5 -$509K 4 Jan 3, 2024 President, Head of Global Oncology Research and Development
PSTX Poseida Therapeutics, Inc. May 1, 2023 2 $0 4 May 2, 2023 Director
PSTX Poseida Therapeutics, Inc. Apr 13, 2023 0 $0 3 Apr 14, 2023 Director
ZLAB Zai Lab Ltd Apr 3, 2023 2 $0 4 Apr 5, 2023 President, Head of Global Oncology Research and Development
ZLAB Zai Lab Ltd Dec 30, 2022 2 $0 4 Jan 3, 2023 President, Head of Global Oncology Research and Development
ZLAB Zai Lab Ltd Dec 30, 2022 0 $0 3 Jan 3, 2023 President, Head of Global Oncology Research and Development Exhibit List: Exhibit 24 - Power of Attorney
ALLO Allogene Therapeutics, Inc. Oct 7, 2022 2 -$100K 4 Oct 11, 2022 EVP of R&D
ALLO Allogene Therapeutics, Inc. Oct 3, 2022 1 -$99.2K 4 Oct 5, 2022 EVP of R&D
ALLO Allogene Therapeutics, Inc. Aug 2, 2022 1 -$23.9K 4 Aug 2, 2022 EVP of R&D and CMO
ALLO Allogene Therapeutics, Inc. Jul 5, 2022 1 -$22.9K 4 Jul 6, 2022 EVP of R&D and CMO
ALLO Allogene Therapeutics, Inc. Jun 21, 2022 1 -$22.4K 4 Jun 22, 2022 EVP of R&D and CMO
ALLO Allogene Therapeutics, Inc. May 19, 2022 1 -$85.1K 4 May 19, 2022 EVP of R&D and CMO
ALLO Allogene Therapeutics, Inc. Mar 23, 2022 2 $0 4 Mar 25, 2022 EVP of R&D and CMO
ALLO Allogene Therapeutics, Inc. Mar 15, 2022 1 -$39.8K 4 Mar 17, 2022 EVP of R&D and CMO
ALLO Allogene Therapeutics, Inc. Oct 1, 2021 1 -$280K 4 Oct 4, 2021 EVP of R&D and CMO
ALLO Allogene Therapeutics, Inc. May 18, 2021 1 $0 4 May 20, 2021 EVP of R&D and CMO